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Non-steroidal anti-inflammatory drugs (NSAIDs) are
associated with type I hypersensitivity, including cutaneous
manifestations (e.g., urticaria and angioedema), respiratory
manifestations (rhinitis, nasal polyposis, asthma), and ana-
phylaxis. To assess the sensitivity/specificity of in vitro
tests for verifying the causative/tolerant drugs and cross-
reactivity of different NSAIDs, we used three assays,
including two ELISA tests for histamine/leukotriene C4
(LTC4) release, and a flow cytometric basophil activation
test (BAT). We recruited 82 patients with NSAIDs-
induced type I hypersensitivity (angioedema of the most
cases), and isolated the peripheral leukocytes to perform
histamine/LTC4 release tests in 38 patients, and BAT in
44 patients. The cell response to NSAIDs was examined in
the incubation containing suspected or tolerant drugs with
concentrations equal to 1-fold (physical level) or 10-fold
Cmax. Comparing with the data of solve controls of the
same subject, positive response was considered if the hista-
mine/LTC4 release showed 1.2-fold increase, and BAT
detected more than 5% increase of CD63+/CCR3+ cells.
We found that histamine release test had a sensitivity of
41.9% (26/62), and specificity of 100% (10/10).LTC4
release test had a sensitivity of 32.3% (20/62), and specifi-
city of 90% (9/10). BAT had a sensitivity of 46.4% (39/84)
and specificity of 90% (18/20) for NSAIDs-induced type I
hypersensitivity. Regarding drug classification, the four
most common clinically suspected agents were aspirin,
ibuprofen, diclofenac, and acetaminophen. The three
assays have consistently >50% sensitivity for verifying
aspirin, but various sensitivity and diverse individual
response for the other NSAIDs. Heterogeneous mechan-
isms including both immunology and pharmacology may
be involved in NSAIDs-induced type I hypersensitivity.
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